Abbott reports weaker-than-expected 4Q revenue

SHARE Abbott reports weaker-than-expected 4Q revenue

Abbott Laboratories Inc. reported weaker-than-expected fourth-quarter revenue, hurt by disappointing sales of its generic medicines and the lingering impact of an overseas recall of its baby formulas last summer, Reuters reports.

Company officials further spooked investors by forecasting in a conference call that earnings in the first quarter of 2014 would be well below Wall Street expectations. Abbott’s full-year forecast, however, was in line with analyst forecasts and reflects likely double-digit earnings growth.


The Latest
Cunningham has worked for the Bears since 2022.
The White House on Wednesday will officially announce Biden’s intention to nominate April Perry to be a U.S. District Court judge. For months, the effort to confirm Perry as Chicago’s new U.S. Attorney was stalled by Sen. J.D. Vance, a Republican from Ohio.
Stacey Greene-Fenlon became the first woman and first person not connected to Chicago government to chair the Chicago fishing advisory committee on Thursday.
Nutritionists say the general trend of consumers seeking out healthier beverages is a good one. But experts also say people should be cautious and read ingredient labels.
The beloved South Side blues club will kick off its long-awaited return with two shows featuring John Primer and the Real Deal.